key: cord-0425583-uqkgnboi authors: RodanSarohan, Aziz; Akelma, Hakan; Araç, Eşref; Aslan, Özgür; Cen, Osman title: Retinol Depletion in COVID-19 date: 2022-05-28 journal: nan DOI: 10.1016/j.nutos.2022.05.007 sha: 572819a61a578b5ffb8b6b7761eebffa070fcc0b doc_id: 425583 cord_uid: uqkgnboi Background and Aims COVID-19 hasbeen a devastatingpandemic. There are indications that vitamin A is depleted during infections. Vitamin A is important in development and immune homeostasis. It has been used successfully in measles, RSV and AIDSinfections. In this study, we aimed to measurethe serum retinol levels in severe COVID-19 patients to assessthe importance of vitamin A in the COVID-19 pathogenesis. Methods The serum retinol level was measured in two groups of patients: the COVID-19 group, which consisted of 27 severe COVID-19 patients hospitalized in the intensive care unit with respiratory failure, and the control group, which consisted of 23 patients without COVID-19 symptoms. Results The mean serum retinol levels were 0.37 mg/L in the COVID-19 group and 0.52 mg/L in the control group. The difference between the serum retinol levels in the two groups was statistically significant.There was no significant difference in retinol levels between different ages and genders within the COVID-19 group. Comorbidity did not affect serum retinol levels. Conclusion The serum retinol level was significantly lower in patients with severe COVID-19, and this difference was independent of age or underlying comorbidity.Our data show that retinol and retinoic acid signaling might be important in immunopathogenesis of COVID-19. COVID-19, which is caused by SARS-CoV-2, emerged in December 2019, and was declared a pandemic by the World Health Organization (WHO) in March 2020 (1, 2) . So far, by end of fall of 2021, more than 250 million people have been infected with more than 5 million deaths worldwide (3) . The COVID-19 pandemic causes serious socioeconomic consequences and continues to be a major worldwide health problem (1, 2) . Vaccines have been developed for prevention of COVID-19 in an unprecedented speed (4, 5) . However, the effectiveness of currently available vaccinesvaries and immunity they induce declinesfast (6, 7) . In addition, some vaccines may induce side effects in rare cases (8, 9) and some vaccinated people are still getting infected indicating incomplete protection of vaccines (6, 10) .Furthermore, emergence of more contagious mutant variants such as delta and omicron has further heightened its public health concerns (6, 10) .Even though a couple of antiviral drugs against COVID-19have recently been developed, their effectiveness needs to be proven (11) (12) (13) .Hence, the search for effective and specific anti-COVID-19 drugs and treatment strategies continue throughout the world (14) . Repurposing of existing drugs or identifying effective prevention approaches are important in helping control the spread of COVID-19 and decreasing its devastating impact. Vitamin A has a seminal role in the development and homeostasis of many organ systems including nervous and immune systemsanddevelopment of proper immunity against viral infections (15, 16) . The protective effects of Vitamin A against infections have been known for a long time. The WHO added vitamin A prophylactically to its measles pandemic prevention programs in the 1950s, which achieved successful results and reduced mortality rates due to pneumonia by 50% (17, 18) . Retinol has been successfully used in AIDS patients and was effective in decreasing morbidity and mortality due to other viral infections in AIDS (19) . The multi-organ effect of vitamin A is accomplished through retinoic acid signaling,whichalso has a central and indispensable role in the immune defense mechanism (20) (21) (22) . One of the most potent antiviral immune responses is Type-I interferon(IFNα and IFNβ), whose synthesis is regulated through retinoic acid signaling pathway via retinoic acid receptors (RXR and RAR) and transcription factors in Retinoic acid-Inducible Gene-I (RIG-I) pathway (23) (24) (25) (26) . Type-I IFN prevents viral replication through recognition of viral RNA and regulation of the host immune system(25). It activates cytotoxic T cells and induces antibody synthesis by activating B lymphocytes through T helper cells (27, 28). Vitamin A deficiency is associated with deregulated immune response. Vitamin A deficiency causes disruption of mucosal barriers in the gastrointestinal and respiratory systems and a decrease the number and function of monocytes, macrophages, natural killer cells, and T and B lymphocytes, plasma cells, and antibody response (15, (29) (30) (31) . Vitamin A deficiency leads to an increased predisposition to infections as well as increased clinical severity of diseases(30, 32). Vitamin A deficiency reduces host resistance to viral infections through impaired interferon production(33-35).For example, Vitamin A deficiency is associated with the increased frequency and mortality rates of Measles, Varicella, RSV, AIDS, and viral pneumonia (16, 18, 31, 34) . Infectious diseases can contribute to vitamin A deficiency by suppressing circulatory retinol (36) .In addition, vitamin A stores may become depleted during infections such as measles, RSV, HIV, and viral pneumoniaincluding COVID-19 (34, [37] [38] [39] , leading to impaired interferon response and causing a vicious infection cycle (36, 40) . As the serum retinol is consumed, it is being supplemented from the large retinol stores in liver and other body stores (34, 39, 40) . Therefore, the serum retinol level is reduced only after Vitamin A deficiency progresses following depletion of body's large Vitamin A stores and detection of low serum retinol level J o u r n a l P r e -p r o o f means that retinol stores in the liver were already significantly depleted (40) . During systemic infections, high fever also increases metabolic use and urinary excretion and reduces apparent retinol stores (39) . Measles especially disrupts Vitamin A metabolism, negatively affecting the use as well as the storage of Vitamin A (18, 41) . Most immunopathological changes observed in severe COVID-19 patients mimic those of vitamin A deficiency (1, 42) . In severe COVID-19 cases, neutrophil and white blood cells are elevated, while total lymphocyte count, CD4and CD8 positive T cells, regulatory T cells,memory T cells, natural killer and B cells are decreased, as well as antibody synthesis, and thus humoral immunity is also impaired (43) (44) (45) . Therefore, retinol depletion and retinoid signaling disorder in COVID-19 may also be responsible for the development of reinfection due to defect in interferon production, persistence of infection, and insufficient antibody responses after primary infection(34, 46, 47) .In this study, we aimed to measure retinol level in the serum of COVID-19 and control patients to evaluatethe role of retinol and retinoid signaling in the pathogenesis of COVID-19. Nutrition solutions administered to the patients were determined retrospectively. No diet restriction was applied to conscious patientswho could be fed orally. These patients continued to eat regular hospital meals. However, twelve patients in the COVID-19 group, who could not be fed orally, were fed through a nasogastric tube or parenteral routeusing various nutritional formulas containing polyunsaturated fatty acid (omega3) and multivitamins including vitamin A and vitamin D (supplemental material). The COVID-19 group continued receiving (due to ethical concerns) the drugs containing the active ingredient of Favipiravir and hydroxychloroquine that were used for the treatment of COVID-19. Favipiravir is inhibitor of RNA dependent RNA polymerase of various RNA viruses [44] . Hydroxychloroquine is an inhibitor of lysosomal pathway and autophagy and is traditionally used for treatment of malaria [45, 46] . It also inhibits cytochrome oxidase P450 enzymes in the liver and therefore preventshepatic retinol excretion [47] . immunoassayusing Cobas e601 (Roche diagnostics, Germany). (MindrayBuilding, High-Tech IndustrialPark, Nanshan,Shenzhen China). The statistical analysis of data was performed using IBM SPSS 22.00 for Windows program (Statistical Package for Social Sciences, Chicago, IL, USA). The Shapiro-Wilk Test was used to test for the normal distribution of the data. All data in all groups, except for ferritin level in the control group, were compliant with the normality assumption. TheMann-Whitney U Testwas used to assess the significance of differences between the groups and between subgroups within COVID-19 group. In all statistical analysis, the p<0.05 was considered statistically significant. J o u r n a l P r e -p r o o f The mean serum retinol level was 0.37 mg/L in the COVID-19 patient group (SD=+/-0.15) and 0.52 mg/L in the control group (SD=+/-0.09). The difference in the retinol levels between the two groups was statistically significant (P<0.001) ( Table 2 ). However, no significant difference was found in retinol levels between the female and male subgroups within COVID-19group (p>0.05) ( Table 2 ). The average age of the patient in the COVID-19 group was 63.2 years, while that of the control group was 44.8 years. The age difference between the two groups was statistically significant (p<0.001) ( Table 2 ). To correct for the age-related variability of retinol levels, the patient group was stratified into two age subgroups with cut-off of 60 years of age: 60 years of age and under (N=10) and over 60 years of age (N=17). The difference in the serum retinol levels between these two age subgroups within the COVID-19 patient group was not statistically significant (p> 0.05) ( Table 3 ). The mean serum retinol level was 0.38 mg/L in the group with 60 years of age and below (SD=+/-0.21) and 0.36 mg/L in the group of above 60 years of age (SD=+/-0.12). In the COVID-19 group, 25 patients received Favipiravir and 2 received hydroxychloroquine. Despite the use of these drugs, their retinol levels were still significantly lower compared to those of the control group (P< 0.001).Ten patients in the COVID-19 group were given various nutritional supplements, some of which also contained Vitamin A (supplemental material). Even J o u r n a l P r e -p r o o f though the average retinol level in the group that received nutritional supplementwas higher, this difference was not statistically significant (P>0.05). Ten of 27 patientsin COVID-19 group received nutritional supplement. Nine of these 10 patients (90%) died, and 8 of these 9 patients also had another comorbid diseasethat posed a high risk for morbidity and mortality ( Table 1 ). Three of the 17 patients who did not receive nutritional supplementdied. There was a statistically significant correlation between nutritional supplement and deathrate (P<0.001). However, this correlation seems to be due to comorbidity and not due to the nutritional supplementation as 8 out of 9 patients had a comorbidity. No significant difference was found in serum retinol levels between these two groups. Twelve of 27 patients in theCOVID-19 group died. There was no significant difference in retinol levels between those who died and those who were discharged (P>0.05). Theserum ferritin level and lymphocyte counts were also evaluated. Ferritin levels were found high and lymphocyte counts were found low in the COVID-19 group compared to the control group (Table 4 ). These findings were compliant with the findings of clinical studies in the literature and were associated with poor prognosis in COVID-19 [50, 51] . Even though the size of our study is small, our results show acorrelation between serum retinol level and severe COVID-19 infection which supports the retinol depletion and retinoid signaling Our results support the previous studies that COVID-19 is more severe in elderly patients(2, 52). Since the average age of severe COVID-19 patients in our study was higher, we tested whether the age might affect the serum retinol level by stratifying the COVID-19 patients according to the age. We did not find a significant difference in retinol levels between the age subgroups, younger versus older than 60 years of age. It seems that the difference in retinol levels between the COVID-19 group and the control group is not directly related to age, but could be caused by the COVID-19 infection itself. Twelve patients in the COVID-19 group died. It is likely that the death of these patients was contributed to by their comorbid diseases and that the low level of vitamin A, despite supplementation, did not provide any protective help. It is tempting to argue that a possible very low level of vitamin A and retinoic acid at the beginning of the infection might have allowed an increased inflammation and the severe disease pathogenesis. Our data show no significant differences in the serum retinol levels between the patients with and without comorbidity within the COVID-19group. We expected low vitamin A levels in the comorbid group due to the inflammatory processes of chronic diseases. Some comorbid patients taking nutritional supplement that alsocontainedvitamin A might have affectedthis result. It is important to note that due to the limited resources and urgency of some clinical data early during COVID-19 pandemic, our study size was kept very small. A limitation of our study might be that it is possible, even though less likely that any asymptomatic COVID-19 patients that might have been in the control group would have skewed our results since we did not perform RT-PCR test due to resource limitations. Supplementation of vitamin A in the administered fortified nutrition mixdid not seem to influencethe serum retinol leveldespite slightly increasing it. This may be due to the low doses of vitamin A in the nutritional supplement and high rate of consumption due to severe disease pathology. Studies show that the effect of vitamin A use is dose-dependent and high doses should be used before or at the beginning of the infection before the severe inflammatory process involve multi-organ damage as it is also the case in for vitamin D (53) (54) (55) (56) . Likewise, vitamin A may suppress excessive inflammatory processes only at normal serum levels and at the therapeutic doses(34, 49, 57) Vitamin A has a similar effect as vitamin D in the COVID-19 pathology as both vitamins involve retinoid signaling in regulating proper immune response. The role of vitamin D has been recognized in the treatment of COVID-19 at high enough doses (58) (59) (60) .Vitamin D is effective in mild to moderate COVID-19, whereas failure to respond to vitamin D supplementation in severe COVID-19 may be due to vitamin A depletion. Because nuclear steroid hormone receptors, J o u r n a l P r e -p r o o f including the vitamin D receptor, act as heterodimeric receptors in complex with the retinoid X receptor (RXR). Therefore, deficiency in vitamin A and D may perturb retinoid signaling which then may lead to skewed immune response.The RXR receptor is needed not only for vitamins A and D, but also for other steroid compounds to have an effect. (61, 62) . The reason why the regulation mechanism of endogenous retinoic acids has not been noticed until now in COVID-19 may be the assumption that retinoic acid, an endogenous retinoid signaling ligand, can always be present in the body. However, the amount of retinoic acid in the human body is limited and is sufficient for approximately three months for a person (63, 64) . Serum retinol levels drop only after the deficiency has progressed to severe levels and the largescale stores of vitamin A in the liver are depleted,and by the time the serum retinol levels are found to be low, the liver retinol stores will already be largely depleted (65). Retinol and retinoic acids can be rapidly depleted due to reasons such as excessive viral load, high fever, and catabolic destruction, especially with continuous and long-term RIG-I stimulation (64, 66) . STRA6, the receptor that take vitamin A into the cells, has recently been reported to be a receptor, in addition to ACE, for the spike protein of SARS-CoV2 to infect cells (67) . It will be interesting to to know how the use of retinol receptor by the virus might affect vitamin A internalization and metabolism as well as its immunoregulatory function. We anticipated that retinoic acid excretion might have been lower in women than in men due to the estradiol effect. Estradiol inhibits many more enzymes within the CYP450 system than testosterone, which inhibits only CYP2D6 (66, 68, 69 ).The CYP450 system is less suppressed in men than in women (70, 71) . Based on this role of estradiol on CYP450 enzymes, we expected higher retinol levels in women than in men. However, our results show no significant difference J o u r n a l P r e -p r o o f in retinol levels between male and female subgroups. We believe this may have been affected by the low number of cases, the non-homogeneity of the patient group, the use of CYP450 inhibitory drugs, and the administration of dietary supplements containing vitamin A to the patients. A well-controlled larger study shall yield more reliable results about the difference in retinol metabolism between men and women in COVID-19. If some specific enzymes of the CYP450 system are inhibited, the metabolism of retinoic acids will also be inhibited, raising intracellular RA levels reaching to thetherapeutic levels. For this purpose, agents that block the metabolism of retinoic acids, called RAMBAs (retinioic acid metabolism blocking agents) have been developed (72) (73) (74) (75) .Early treatment with such inhibitors in COVID-19 may increase endogenous retinoic acid levels by preventing retinoic acid metabolism inliver (72) . Thus, in COVID-19, Type-I interferon can be synthesized early during infection, and the virus can be cleared from the body without worsening the disease pathogenesis(27, 76). Recent molecules docking and genome wide association studies on the pathogenesis of COVID-19 points to the importance of retinol and retinoic acid signaling (67, (77) (78) (79) . Detailed understanding of the pathogenesis of COVID-19 will increase our ability to develop prophylactic and treatment options for COVID-19. While COVID-19 may be mild or asymptomatic in some people, it may be very serious in some others. We think that this clinical difference is highly correlated with the state of retinol stores in the body. Malnutrition, comorbid disease, chronic lung and liver diseases, obesity, hepatosteatosis, chronic inflammation, febrile diseases, and excessive antigenic stimulation J o u r n a l P r e -p r o o f allmay cause depletion of retinol stores and weaken immune defense against pathogens including SARS-CoV-2 (49, 65) . A sufficient level of retinol and retinoic acid may help generate type-I interferon response to SARS-CoV-2 infection (80) .Even though small, our study found that serum retinol levels were significantly low in patients with severe COVID-19. Given the potential for many overlooked factors to affect retinol levels, prospective clinical studies with larger, more carefully selected case groups are needed to identify the role of vitamin A or retinoids in COVID-19 treatment. Such studies will also shed light on the detailed pathogenesis of COVID-19 and provide guidelines for COVID-19 treatment and prophylaxis. However, even though the lack of vitamin A has serious health consequences, overdose of retinol and retinoids will cause serious consequences (81) (82) (83) . Therefore, retinol and carotenoids may be supplemented to the vitamin A deficient individuals. However, the use of retinoids and ATRA for treatment or prophylaxis must be under the supervision of medical professionals to evade the toxic effect of overdosing of vitamin A. We would like to thank Dr. Murat Kizil for scientific and moral support for the study. We would also like to thank Mustafa Kemal Çelen for editorial and clerical support. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The authors declare no conflict of interest. No author is affiliated with any undeclared institution or financial relationship that could affect the objectivity of this study. ARS conceived, created, and reviewed the literature, and wrote the project, protocol, and manuscript. HA selected patient and screened patient files. EA involved in official submission and follow-up of the protocol to the ethics committee. ÖA performed the statistical analysis of the data. OC reviewed literature, discussed, revised, re-organized, and re-wrote the manuscript. • High blood pressure (6) • Type II diabetes (3) • Chronic kidney disease (2) • Asthma (1) • Heart disease (1) • Hypothyroidism (1) • Peripheral vascular disease (1) • Surrenal fibrosis (1) J o u r n a l P r e -p r o o f Table 3 . Retinol levels in the sub-age groups in the COVID-19 group. Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19) Epidemiology, Pathogenesis, and Control of COVID-19 COVID-19) Dashboard [Website]. World Health Organization COVID-19 vaccines: The status and perspectives in delivery points of view. Advanced drug delivery reviews SARS-CoV-2 vaccines in development An overview of SARS-COV-2 epidemiology, mutant variants, vaccines, and management strategies A perspective on discussing COVID-19 vaccines: Efficacy and adverse effects Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies A Rare Case of Cerebral Venous Thrombosis and Disseminated Intravascular Coagulation Temporally Associated to the COVID-19 Vaccine Administration COVID-19 vaccinations: The unknowns, challenges, and hopes Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial Molnupiravir-A Novel Oral Anti-SARS-CoV-2 Agent Covid-19: Pfizer's paxlovid is 89% effective in patients at risk of serious illness, company reports Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods Vitamin A, Infection, and Immune Function*. Annual review of nutrition Vitamin A, infectious disease, and childhood mortality: a 2 solution? The Journal of infectious diseases Combining vitamin A and vaccines: convenience or conflict? Danish medical journal Vitamin A for treating measles in children. The Cochrane database of systematic reviews Effects of vitamins, including vitamin A, on HIV/AIDS patients. Vitamins and hormones Vitamin A and retinoid signaling: genomic and nongenomic effects Retinoic acid signaling pathways Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway Vitamin A and immune regulation: role of retinoic acid in gut-associated dendritic cell education, immune protection and tolerance. Molecular aspects of medicine Vitamin A deficiency impairs adaptive B and T cell responses to a prototype monovalent attenuated human rotavirus vaccine and virulent human rotavirus challenge in a gnotobiotic piglet model Effect of an infection on vitamin A status of children as measured by the relative dose response (RDR). The American journal of clinical nutrition Vitamin A for non-measles pneumonia in children. The Cochrane database of systematic reviews Emerging roles for retinoids in regeneration and differentiation in normal and disease states Decrease in serum levels of retinol and its binding protein (RBP) in infection The vicious cycle of vitamin a deficiency: A review. Critical reviews in food science and nutrition Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. The Cochrane database of systematic reviews The Immune Response and Immunopathology of COVID-19 Hematological findings in coronavirus disease 2019: indications of progression of disease Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou Interplay between SARS-CoV-2 and the type I interferon response Evasion of Type I Interferon by SARS-CoV-2 Serum retinol concentrations for determining the prevalence of vitamin A deficiency in populations A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder COVID-19: Endogenous Retinoic Acid Theory and Retinoic Acid Depletion Syndrome Systemic Organ Involvement and Retinoid Signaling Disorder in COVID-19 The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak Role of Vitamin A in the Immune System Modulation of T cell and innate immune responses by retinoic Acid Association of Vitamin D Levels, Race/Ethnicity, and Clinical Characteristics With COVID-19 Test Results Vitamin D in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis Seropositivity Among Working-Age Adults Vitamin D high doses supplementation could represent a promising alternative to prevent or treat COVID-19 infection. Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis Vitamin deficiency as risk factor for SARS-CoV-2 infection: correlation with susceptibility and prognosis. European review for medical and pharmacological sciences Vitamin D: Classic and Novel Actions Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial Gene expression regulation by retinoic acid Cytochrome P450s in the regulation of cellular retinoic acid metabolism. Annual review of nutrition CYP2A6: a human coumarin 7-hydroxylase Abo El Magd MF. STRA6 (vitamin A receptor), as a Novel binding receptor of COVID-19 Human cytochrome P450: metabolism of testosterone by CYP3A4 and inhibition by ketoconazole. Current protocols in toxicology The role of cytochrome P450 in developmental pharmacology. The Journal of adolescent health : official publication of the Society for Adolescent Medicine Superoxide dismutase and cytochrome P450 isoenzymes might be associated with higher risk of renal cell carcinoma in male patients Sexually dimorphic regulation of hepatic isoforms of human cytochrome p450 by growth hormone Therapeutic potential of the inhibition of the retinoic acid hydroxylases CYP26A1 and CYP26B1 by xenobiotics. Current topics in medicinal chemistry Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases First chemical feature-based pharmacophore modeling of potent retinoidal retinoic acid metabolism blocking agents (RAMBAs): identification of novel RAMBA scaffolds Retinoic acid metabolism blocking agents (RAMBAs): a new paradigm in the treatment of hyperkeratotic disorders A role for retinoids in the treatment of COVID-19? Clinical and experimental pharmacology & physiology Genomewide Association Study of Severe Covid-19 with Respiratory Failure. The New England journal of medicine Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. medRxiv Could the candidate causal gene (LZTFL1) identified by Oxford University scientists, which doubles the risk of COVID-19-related respiratory failure, be used to boost the Weak immunogenicity of COVID-19 mRNA vaccines in patients with B-cell chronic lymphocytic leukemia (CLL)??? All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells Prolonged overdose of all-trans retinoic acid enhances bone sensitivity in castrated mice Retinoic acid in developmental toxicology: Teratogen, morphogen and biomarker The vitamin A spectrum: from deficiency to toxicity. The American journal of clinical nutrition Protein: 28% E; 14 g/200 ml (Casein), Fat: 24% E; 5.4 g/200 ml (saturated, singlepoly unsaturated fat Administered to 2 individuals, 10 pcs and 29 pcs Fresenius container. 3 pcs were used in 1 individual. 100 ml contains; 10.0 g fish oil refined at high temperature: 1.25-2.82 g Eicosapentaenoic Acid (EPA) Oligoclinomel N7-1000 E electrolyte amino acid solution, glucose solution, lipid emulsion.1500 ml three-chamber bag. 7 pcs were used in 1 individual. 100 ml contains refined olive oil (80%) + Refined soya oil (20%): 4 g, essential amino acids and Sodium acetate 3EE0: 0.245 g Magnesium chloride 6H2O: 0.045 g, Glucose (17.6 g glucose monohydrate):16 g Novasource® GI Control 500 ml. Nestle. 8 pcs were used in 1 individual 500 ml (milk protein), Carbohydrate 53% E; 72.5 g/500 ml, Fat 29% E; 17.5 g/500 ml. (saturated, single-poly unsaturated fat, MCT 200 ML. Nutricia. 28 pcs were used in 1 individual. 100 gram contains 700 g Saturated Fat, 3.400 g Single Saturated Fat, 1.700 g Polyunsaturated Fat Resource® Energy 200ml. Nestlé Health Science. 38, 53 and 65 pcs were used in 3 individuals. Protein: 15% E-11.2 g/200 ml (Casein), Carbohydrate: 55% E-42 g/200 ml (Maltodextrin, sucrose), Fat: 30% E -10 g/200 ml Baxter Healthcare Corporation. 3 people were used. There are 1, 4 and 5 pieces Vitamin D3 (Cholecalciferol) 220 IU, Vitamin E 11.2 IU, Vitamin C 125 mg, B Complex vitamins The authors declare no conflict of interest. No author is affiliated with any undeclared institution or financial relationship that could affect the objectivity of this study.